Dr. Fiona Lovegrove reports live from the 2023 EADV Congress in Berlin and discusses the late breaking presentation on the efficacy and safety of abrocitinib for prurigo nodularis in chronic pruritis.
top of page
bottom of page
Dr. Fiona Lovegrove reports live from the 2023 EADV Congress in Berlin and discusses the late breaking presentation on the efficacy and safety of abrocitinib for prurigo nodularis in chronic pruritis.